392 related articles for article (PubMed ID: 28903345)
21. MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.
Mlcochova J; Faltejskova-Vychytilova P; Ferracin M; Zagatti B; Radova L; Svoboda M; Nemecek R; John S; Kiss I; Vyzula R; Negrini M; Slaby O
Oncotarget; 2015 Nov; 6(36):38695-704. PubMed ID: 26497852
[TBL] [Abstract][Full Text] [Related]
22. The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma.
Jiang Y; Luan Y; Chang H; Chen G
Oncol Lett; 2018 Sep; 16(3):4001-4007. PubMed ID: 30128020
[TBL] [Abstract][Full Text] [Related]
23. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
[TBL] [Abstract][Full Text] [Related]
24. Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma.
Calsina B; Castro-Vega LJ; Torres-Pérez R; Inglada-Pérez L; Currás-Freixes M; Roldán-Romero JM; Mancikova V; Letón R; Remacha L; Santos M; Burnichon N; Lussey-Lepoutre C; Rapizzi E; Graña O; Álvarez-Escolá C; de Cubas AA; Lanillos J; Cordero-Barreal A; Martínez-Montes ÁM; Bellucci A; Amar L; Fernandes-Rosa FL; Calatayud M; Aller J; Lamas C; Sastre-Marcos J; Canu L; Korpershoek E; Timmers HJ; Lenders JW; Beuschlein F; Fassnacht-Capeller M; Eisenhofer G; Mannelli M; Al-Shahrour F; Favier J; Rodríguez-Antona C; Cascón A; Montero-Conde C; Gimenez-Roqueplo AP; Robledo M
Theranostics; 2019; 9(17):4946-4958. PubMed ID: 31410193
[No Abstract] [Full Text] [Related]
25. Circulating miRNA in functional tricuspid regurgitation. Unveiling novel links to heart failure: A pilot study.
Hinojar R; Moreno-Gómez-Toledano R; Conde E; Gonzalez-Gomez A; García-Martin A; González-Portilla P; Fernández-Golfín C; García-Bermejo ML; Zaragoza C; Zamorano JL
ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38638083
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures.
Kocijan R; Muschitz C; Geiger E; Skalicky S; Baierl A; Dormann R; Plachel F; Feichtinger X; Heimel P; Fahrleitner-Pammer A; Grillari J; Redl H; Resch H; Hackl M
J Clin Endocrinol Metab; 2016 Nov; 101(11):4125-4134. PubMed ID: 27552543
[TBL] [Abstract][Full Text] [Related]
27. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer.
Jacob H; Stanisavljevic L; Storli KE; Hestetun KE; Dahl O; Myklebust MP
Oncotarget; 2017 Oct; 8(50):87837-87847. PubMed ID: 29152124
[TBL] [Abstract][Full Text] [Related]
28. miRNA profiling of small intestinal neuroendocrine tumors defines novel molecular subtypes and identifies miR-375 as a biomarker of patient survival.
Arvidsson Y; Rehammar A; Bergström A; Andersson E; Altiparmak G; Swärd C; Wängberg B; Kristiansson E; Nilsson O
Mod Pathol; 2018 Aug; 31(8):1302-1317. PubMed ID: 29487354
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
30. Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes.
Wander PL; Boyko EJ; Hevner K; Parikh VJ; Tadesse MG; Sorensen TK; Williams MA; Enquobahrie DA
Diabetes Res Clin Pract; 2017 Oct; 132():1-9. PubMed ID: 28783527
[TBL] [Abstract][Full Text] [Related]
31. Association of recurrent venous thromboembolism and circulating microRNAs.
Wang X; Sundquist K; Svensson PJ; Rastkhani H; Palmér K; Memon AA; Sundquist J; Zöller B
Clin Epigenetics; 2019 Feb; 11(1):28. PubMed ID: 30760335
[TBL] [Abstract][Full Text] [Related]
32. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
Lian F; Cui Y; Zhou C; Gao K; Wu L
PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
[TBL] [Abstract][Full Text] [Related]
33. Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients' plasma.
Niedra H; Peculis R; Litvina HD; Megnis K; Mandrika I; Balcere I; Romanovs M; Steina L; Stukens J; Breiksa A; Nazarovs J; Sokolovska J; Liutkeviciene R; Vilkevicute A; Konrade I; Rovite V
Front Oncol; 2022; 12():894317. PubMed ID: 36158656
[TBL] [Abstract][Full Text] [Related]
34. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
[TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
36. Analysis of plasma microRNA expression profiles in male textile workers with noise-induced hearing loss.
Ding L; Liu J; Shen HX; Pan LP; Liu QD; Zhang HD; Han L; Shuai LG; Ding EM; Zhao QN; Wang BS; Zhu BL
Hear Res; 2016 Mar; 333():275-282. PubMed ID: 26278637
[TBL] [Abstract][Full Text] [Related]
37. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
38. Serum MiRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase.
Tan Y; Ge G; Pan T; Wen D; Gan J
Clin Chim Acta; 2015 Dec; 451(Pt B):232-9. PubMed ID: 26483130
[TBL] [Abstract][Full Text] [Related]
39. Circulating serum miRNAs as potential biomarkers for nephroblastoma.
Ludwig N; Nourkami-Tutdibi N; Backes C; Lenhof HP; Graf N; Keller A; Meese E
Pediatr Blood Cancer; 2015 Aug; 62(8):1360-7. PubMed ID: 25787821
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of microRNA expression in plasma and skeletal muscle of thoroughbred racehorses in training.
McGivney BA; Griffin ME; Gough KF; McGivney CL; Browne JA; Hill EW; Katz LM
BMC Vet Res; 2017 Nov; 13(1):347. PubMed ID: 29166903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
